期刊： HAEMATOLOGICA, 2022; 107 (10)
Hematopoietic stem cells (HSC) give rise to the cells of the blood system over the whole lifespan. N6-methyladenosine (m6A), the most prevalent RNA mo......
期刊： HAEMATOLOGICA, 2022; 107 (10)
Chemotherapy is the primary treatment option for acute myeloid leukemia (AML), but leukemic stem cells (LSC) can sur-vive chemotherapy for disease rec......
期刊： HAEMATOLOGICA, 2022; 107 (1)
Hematopoietic stem cells (HSC) are dominantly quiescent under homeostasis, which is a key mechanism of maintaining the HSC pool for life-long hematopo......
期刊： HAEMATOLOGICA, 2022; 107 (10)
Bone marrow (BM) endothelial progenitor cell (EPC) damage of unknown mechanism delays the repair of endothelial cells (EC) and recovery of hematopoies......
期刊： HAEMATOLOGICA, 2022; 107 (6)
Platelet hyperreactivity and increased atherothrombotic risk are specifically associated with dyslipidemia. Peroxisome proliferator-activated receptor......
期刊： HAEMATOLOGICA, 2022; 107 (6)
beta(654)-thalassemia is a prominent Chinese subtype of beta-thalassemia, representing 17% of all cases of beta-thalassemia in China. The molecular me......
期刊： HAEMATOLOGICA, 2021; 106 (8)
Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (>1000 mg/dL) during therapy i......
期刊： HAEMATOLOGICA, 2021; 106 (5)
Mantle cell lymphoma (MCL) with MYC rearrangement (MYC-R) is rare and little is known about the importance of MYC extra copies (EC) in the absence of ......
